Carl Zeiss Meditec AG (CHIX:AFXD) EBIT per Share : €3.49 (TTM As of Jun. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Carl Zeiss Meditec AG EBIT per Share?

Carl Zeiss Meditec AG's EBIT per Share for the three months ended in Jun. 2024 was €0.64. Its EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2024 was €3.49.

During the past 12 months, the average EBIT per Share Growth Rate of Carl Zeiss Meditec AG was -27.10% per year. During the past 3 years, the average EBIT per Share Growth Rate was 25.20% per year. During the past 5 years, the average EBIT per Share Growth Rate was 14.70% per year. During the past 10 years, the average EBIT per Share Growth Rate was 11.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Carl Zeiss Meditec AG's EBIT per Share or its related term are showing as below:

CHIX:AFXd' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -50.8 Med: 10.9 Max: 25.2
Current: 25.2

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Carl Zeiss Meditec AG was 25.20% per year. The lowest was -50.80% per year. And the median was 10.90% per year.

CHIX:AFXd's 3-Year EBIT Growth Rate is ranked better than
74.93% of 714 companies
in the Medical Devices & Instruments industry
Industry Median: 6.95 vs CHIX:AFXd: 25.20

Carl Zeiss Meditec AG's EBIT for the three months ended in Jun. 2024 was €57 Mil.

Carl Zeiss Meditec AG EBIT per Share Historical Data

The historical data trend for Carl Zeiss Meditec AG's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Carl Zeiss Meditec AG EBIT per Share Chart

Carl Zeiss Meditec AG Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

EBIT per Share

Get a 7-Day Free Trial

2.66

2.31

3.90

4.62

4.78

Carl Zeiss Meditec AG Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
EBIT per Share	Get a 7-Day Free Trial															1.52	1.35	0.66	0.84	0.64

Carl Zeiss Meditec AG EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Carl Zeiss Meditec AG's EBIT per Share for the fiscal year that ended in Sep. 2023 is calculated as

	EBIT per Share		(A: Sep. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	427.814	/	89.441
=	4.78

Carl Zeiss Meditec AG's EBIT per Share for the quarter that ended in Jun. 2024 is calculated as

	EBIT per Share		(Q: Jun. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	57.38	/	89.735
=	0.64

EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €3.49

Carl Zeiss Meditec AG (CHIX:AFXd) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Carl Zeiss Meditec AG EBIT per Share Related Terms

Thank you for viewing the detailed overview of Carl Zeiss Meditec AG's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Carl Zeiss Meditec AG Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Carl Zeiss Meditec AG (CHIX:AFXd) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

CZMWY:USA CZMWF:USA 1AFX:Italy 0DHC:UK AFX:Germany AFX:Austria

Address

Goschwitzer Strasse 51-52, Jena, TH, DEU, 07745

Website

https://www.zeiss.com

Carl Zeiss Meditec is one of the largest medical technology companies in the world, and it operates in two segments: ophthalmic devices and microsurgery. OPT, which made up 75% of sales in 2022, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.

Carl Zeiss Meditec AG Headlines

No Headlines